Understanding neuropsychiatric diseases, analyzing the peptide sharing between infectious agents and the language-associated NMDA 2A protein

Frontiers in Psychiatry

Volumn 7, Issue APR, 2016, Pages

  Lucchese, Guglielmo ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cross reactivity; Infectious agents; Language disorders; Neuropsychiatric diseases; NMDA 2A; Peptide sharing

Indexed keywords

BRAIN PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; BRAIN FUNCTION; CROSS REACTION; DISEASE ASSOCIATION; GENE EXPRESSION; GENE LOCATION; IMMUNE RESPONSE; INFECTION; LANGUAGE; MICROORGANISM; NMDA 2A GENE; PEPTIDE ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSYCHOPATHY;

EID: 84975321797     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2016.00060     Document Type: Article

References (51)

1. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology (2011) 76:1006-14. doi: 10.1212/WNL.0b013e31821103e6
2. Mesulam MM, Rogalski EJ, Wieneke C, Hurley RS, Geula C, Bigio EH, et al. Primary progressive aphasia and the evolving neurology of the language network. Nat Rev Neurol (2014) 10:554-69. doi:10.1038/nrneurol.2014.159
3. Solomon M, Olsen E, Niendam T, Ragland JD, Yoon J, Minzenberg M, et al. From lumping to splitting and back again: atypical social and language development in individuals with clinical-high-risk for psychosis, first episode schizophrenia, and autism spectrum disorders. Schizophr Res (2011) 131:146-51. doi:10.1016/j.schres.2011.03.005
4. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol (2010) 119:1-4. doi:10.1007/s00401-009-0612-2
5. Goldberg D. Psychopathology and classification in psychiatry. Soc Psychiatry Psychiatr Epidemiol (2015) 50:1-5. doi:10.1007/s00127-014-0924-y
6. Sieben A, Van Langenhove T, Engelborghs S, Martin JJ, Boon P, Cras P, et al. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol (2012) 124:353-72. doi:10.1007/s00401-012-1029-x
7. Turner SJ, Morgan AT, Perez ER, Scheffer IE. New genes for focal epilepsies with speech and language disorders. Curr Neurol Neurosci Rep (2015) 15:35. doi:10.1007/s11910-015-0554-0
8. Turner SJ, Mayes AK, Verhoeven A, Mandelstam SA, Morgan AT, Scheffer IE. GRIN2A: an aptly named gene for speech dysfunction. Neurology (2015) 84:586-93. doi:10.1212/WNL.0000000000001228
9. Le Ber I, Camuzat A, Guillot-Noel L, Hannequin D, Lacomblez L, Golfier V, et al. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. J Alzheimers Dis (2013) 34:485-99. doi:10.3233/JAD-121456
10. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet (2006) 15:2988-3001. doi:10.1093/hmg/ddl241
11. Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, Puel M, et al. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat (2007) 28:846-55. doi:10.1002/humu.20520
12. Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, de Koning I, et al. Distinct genetic forms of frontotemporal dementia. Neurology (2008) 71:1220-6. doi:10.1212/01.wnl.0000319702.37497.72
13. Flanagan EP, Baker MC, Perkerson RB, Duffy JR, Strand EA, Whitwell JL, et al. Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia. Dement Geriatr Cogn Disord (2015) 39:281-6. doi:10.1159/000375299
14. Sobrido MJ, Abu-Khalil A, Weintraub S, Johnson N, Quinn B, Cummings JL, et al. Possible association of the tau H1/H1 genotype with primary progressive aphasia. Neurology (2003) 60:862-4. doi:10.1212/01.WNL.0000049473.36612.F2
15. Guerreiro RJ, Washecka N, Hardy J, Singleton A. A thorough assessment of benign genetic variability in GRN and MAPT. Hum Mutat (2010) 31:E1126-40. doi:10.1002/humu.21152
16. Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol (2014) 13:686-99. doi:10.1016/S1474-4422(14)70065-1
17. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol (2011) 10:63-74. doi:10.1016/S1474-4422(10)70253-2
18. Doss S, Wandinger KP, Hyman BT, Panzer JA, Synofzik M, Dickerson B, et al. High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types. Ann Clin Transl Neurol (2014) 1:822-32. doi:10.1002/acn3.120
19. Pearlman DM, Najjar S. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Schizophr Res (2014) 157:249-58. doi:10.1016/j.schres.2014.05.001
20. Yolken RH, Torrey EF. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry (2008) 13:470-9. doi:10.1038/mp.2008.5
21. Yolken RH, Dickerson FB, Fuller Torrey E. Toxoplasma and schizophrenia. Parasite Immunol (2009) 31:706-15. doi:10.1111/j.1365-3024.2009.01131.x
22. Torrey EF, Leweke MF, Schwarz MJ, Mueller N, Bachmann S, Schroeder J, et al. Cytomegalovirus and schizophrenia. CNS Drugs (2006) 20:879-85. doi:10.2165/00023210-200620110-00001
23. Lucchese G, Capone G, Kanduc D. Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins. Schizophr Bull (2014) 40:362-75. doi:10.1093/schbul/sbs197
24. Brown AS. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol (2012) 72:1272-6. doi:10.1002/dneu.22024
25. Pequegnat B, Sagermann M, Valliani M, Toh M, Chow H, Allen-Vercoe E, et al. A vaccine and diagnostic target for Clostridium bolteae, an autism-associated bacterium. Vaccine (2013) 31:2787-90. doi:10.1016/j.vaccine.2013.04.018
26. Marienfeld CB, Dicapua DB, Sze GK, Goldstein JM. Expressive aphasia as a presentation of encephalitis with Bartonella henselae infection in an immunocompetent adult. Yale J Biol Med (2010) 83:67-71.
27. Fox JW, Studley JK, Cohen DM. Recurrent expressive aphasia as a presentation of cat-scratch encephalopathy. Pediatrics (2007) 119:e760-3. doi:10.1542/peds.2006-1885
28. Kim KW, Ahn SW, Park KY, Youn YC, Shin HW. Enteroviral encephalitis presenting as rapidly progressive aphasia. J Neurol Sci (2012) 319:156-7. doi:10.1016/j.jns.2012.05.006
29. Noppeney U, Patterson K, Tyler LK, Moss H, Stamatakis EA, Bright P, et al. Temporal lobe lesions and semantic impairment: a comparison of herpes simplex virus encephalitis and semantic dementia. Brain (2007) 130:1138-47. doi:10.1093/brain/awl344
30. Magnus T, Röther J, Simova O, Meier-Cillien M, Repenthin J, Möller F, et al. The neurological syndrome in adults during the 2011 Northern German E. coli serotype O104:H4 outbreak. Brain (2012) 135:1850-9. doi:10.1093/brain/aws090
31. Gable MS, Gavali S, Radner A, Tilley DH, Lee B, Dyner L, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis (2009) 28:1421-9. doi:10.1007/s10096-009-0799-0
32. Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis (2006) 43:1565-77. doi:10.1086/509330
33. Venkatesan A. Advances in infectious encephalitis: etiologies, outcomes, and potential links with anti-NMDAR encephalitis. Curr Infect Dis Rep (2013) 15:594-9. doi:10.1007/s11908-013-0382-9
34. Höftberger R, Armangue T, Leypoldt F, Graus F, Dalmau J. Clinical neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-d-aspartate receptor antibodies are part of the problem. Clin Neuropathol (2013) 32:251-4. doi:10.5414/NP300666
35. O'Donnell LA, Agrawal A, Jordan-Sciutto KL, Dichter MA, Lynch DR, Kolson DL. Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes. J Neurosci (2006) 26:981-90. doi:10.1523/JNEUROSCI.4617-05.2006
36. Gran B, Hemmer B, Martin R. Molecular mimicry and multiple sclerosis-a possible role for degenerate T cell recognition in the induction of autoimmune responses. J Neural Transm Suppl (1999) 55:19-31.
37. The UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res (2015) 43:D204-12. doi:10.1093/nar/gku989
38. Hruz T, Laule O, Szabo G, Wessendorp F, Bleuler S, Oertle L, et al. GENEVESTIGATOR V3: a reference expression database for the meta-analysis of transcriptomes. Adv Bioinformatics (2008) 2008:420747. doi:10.1155/2008/420747
39. Alvarez-Navarro C, Martín-Esteban A, Barnea E, Admon A, López de Castro JA. Endoplasmic reticulum aminopeptidase 1 (ERAP1) polymorphism relevant to inflammatory disease shapes the peptidome of the birdshot chorioretinopathy-associated HLA-A*29:02 antigen. Mol Cell Proteomics (2015) 14:1770-80. doi:10.1074/mcp.M115.048959
40. Keller JM, Surawicz CM. Clostridium difficile infection in the elderly. Clin Geriatr Med (2014) 30:79-93. doi:10.1016/j.cger.2013.10.008
41. Bolte ER. Autism and Clostridium tetani. Med Hypotheses (1998) 51:133-44. doi:10.1016/S0306-9877(98)90107-4
42. Kesli R, Gökçen C, Bulug U, Terzi Y. Investigation of the relation between anaerobic bacteria genus clostridium and late-onset autism etiology in children. J Immunoassay Immunochem (2014) 35:101-9. doi:10.1080/15321819.2013.792834
43. Kanduc D. Pentapeptides as minimal functional units in cell biology and immunology. Curr Protein Pept Sci (2013) 14:111-20. doi:10.2174/1389203711314020003
44. Dudda-Subramanya R, Lucchese G, Kanduc D, Sinha AA. Clinical applications of DNA microarray analysis. J Exp Ther Oncol (2003) 3:297-304. doi:10.1111/j.1533-869X.2003.01104.x
45. Hickok G, Bellugi U, Klima ES. The neural organization of language: evidence from sign language aphasia. Trends Cogn Sci (1998) 2:129-36. doi:10.1016/S1364-6613(98)01154-1
46. Harasty JA, Halliday GM, Kril JJ, Code C. Specific temporoparietal gyral atrophy reflects the pattern of language dissolution in Alzheimer's disease. Brain (1999) 122:675-86. doi:10.1093/brain/122.4.675
47. Duff MC, Brown-Schmidt S. The hippocampus and the flexible use and processing of language. Front Hum Neurosci (2012) 6:69. doi:10.3389/fnhum.2012.00069
48. Vigliocco G, Kousta ST, Della Rosa PA, Vinson DP, Tettamanti M, Devlin JT, et al. The neural representation of abstract words: the role of emotion. Cereb Cortex (2014) 24:1767-77. doi:10.1093/cercor/bht025
49. Ardila A, Bernal B, Rosselli M. How localized are language brain areas? A review of Brodmann areas involvement in oral language. Arch Clin Neuropsychol (2016) 31:112-22. doi:10.1093/arclin/acv081
50. Galton CJ, Patterson K, Graham K, Lambon-Ralph MA, Williams G, Antoun N, et al. Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology (2001) 57:216-25. doi:10.1212/WNL.57.2.216
51. Baumgärtner W, Löscher W. Re-emergence of neuroinfectiology. Acta Neuropathol (2016) 131:155-8. doi:10.1007/s00401-016-1535-3